CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +36,960 | 96,790 | ||
| 2021-01-19 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +2,187 | 98,977 | ||
| 2021-01-19 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +36,960 | 96,790 | ||
| 2021-01-19 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +2,187 | 98,977 | ||
| 2021-01-19 | Malamut Richard EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Purchase) | +105,600 | 105,600 | ||
| 2021-01-19 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +45,780 | 90,175 | ||
| 2021-01-19 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +6,165 | 96,340 | ||
| 2021-01-19 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Purchase) | +130,800 | 130,800 | ||
| 2021-01-19 | Fleming Alison B Chief Technology Officer | Grant or award | +45,360 | 156,779 | ||
| 2021-01-19 | Fleming Alison B Chief Technology Officer | Grant or award | +6,529 | 163,308 | ||
| 2021-01-19 | Fleming Alison B Chief Technology Officer | Grant or award · Stock Option (Right to Purchase) | +129,600 | 129,600 | ||
| 2021-01-19 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +45,360 | 102,891 | ||
| 2021-01-19 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +6,772 | 109,663 | ||
| 2021-01-19 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award · Stock Option (Right to Purchase) | +129,600 | 129,600 | ||
| 2021-01-19 | Brannelly Paul Executive Vice President & CFO | Grant or award | +42,000 | 215,758 | ||
| 2021-01-19 | Brannelly Paul Executive Vice President & CFO | Grant or award | +8,161 | 223,919 | ||
| 2021-01-19 | Brannelly Paul Executive Vice President & CFO | Grant or award · Stock Option (Right to Purchase) | +120,000 | 120,000 | ||
| 2021-01-19 | Ciaffoni Joseph President and CEO | Grant or award | +105,000 | 289,256 | ||
| 2021-01-19 | Ciaffoni Joseph President and CEO | Grant or award | +28,989 | 318,245 | ||
| 2021-01-19 | Ciaffoni Joseph President and CEO | Grant or award · Stock Option (Right to Purchase) | +420,000 | 420,000 |
Page 20 of 24 · 462 trades